KOPP INVESTMENT ADVISORS LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 129 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.9%.

Quarter-by-quarter ownership
KOPP INVESTMENT ADVISORS LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$207,000
+11.3%
11,435
-11.8%
0.20%
+107.1%
Q2 2016$186,000
+13.4%
12,970
-5.3%
0.10%
+11.2%
Q1 2016$164,000
-9.9%
13,700
-0.1%
0.09%0.0%
Q4 2015$182,000
+41.1%
13,710
+14.1%
0.09%
+29.0%
Q3 2015$129,00012,0200.07%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$34,786,00099.98%
Artal Group S.A. 57,517,978$463,019,00019.93%
MASTERS CAPITAL MANAGEMENT LLC 1,129,708$9,094,0000.30%
Rhenman & Partners Asset Management AB 170,915$1,376,0000.16%
Round Table Services, LLC 21,611$174,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$287,0000.10%
FALCON POINT CAPITAL, LLC 37,039$298,0000.10%
SABBY MANAGEMENT, LLC 318,775$2,566,0000.09%
WILLIAM HARRIS INVESTORS INC 39,495$318,0000.09%
HOWARD HUGHES MEDICAL INSTITUTE 51,520$415,0000.09%
View complete list of LEXICON PHARMACEUTICALS INC shareholders